| Overview / Abstract: |
Target Audience Program Overview Learning Objectives Summarize evidence for the efficacy and safety of current agents for the treatment of CSU beyond first-line therapy |
|
Expiration |
Nov 30, 2025 |
|
Discipline(s) |
Nurse Practitioner , Physician CME, Physician Assistant CME |
|
Format |
Online |
|
Credits / Hours |
0.50 AMA PRA Category 1 Credit™ |
|
Accreditation |
ACCME, ANCC |
|
Presenters / Authors / Faculty |
Faculty David M. Lang, MD |
|
Sponsors / Supporters / Grant Providers |
Genentech, a member of the Roche Group. |
|
Keywords / Search Terms |
Relias LLC Relias LLC. FreeCME., chronic spontaneous urticaria (CSU) Free CE CME |